14-67395477-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_016445.3(PLEK2):c.314C>T(p.Ala105Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000116 in 1,461,742 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
PLEK2
NM_016445.3 missense
NM_016445.3 missense
Scores
3
8
8
Clinical Significance
Conservation
PhyloP100: 5.29
Genes affected
PLEK2 (HGNC:19238): (pleckstrin 2) The protein encoded by this gene associates with membrane-bound phosphatidylinositols generated by phosphatidylinositol 3-kinase. The encoded protein then interacts with the actin cytoskeleton to induce cell spreading. In conjunction with complement component 1, q subcomponent, B chain (C1QB), this gene shows an increase in expression in melanoma cells and may serve as an accurate biomarker for the disease. [provided by RefSeq, Dec 2015]
GPHN (HGNC:15465): (gephyrin) This gene encodes a neuronal assembly protein that anchors inhibitory neurotransmitter receptors to the postsynaptic cytoskeleton via high affinity binding to a receptor subunit domain and tubulin dimers. In nonneuronal tissues, the encoded protein is also required for molybdenum cofactor biosynthesis. Mutations in this gene may be associated with the neurological condition hyperplexia and also lead to molybdenum cofactor deficiency. Numerous alternatively spliced transcript variants encoding different isoforms have been described; however, the full-length nature of all transcript variants is not currently known. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLEK2 | NM_016445.3 | c.314C>T | p.Ala105Val | missense_variant | 3/9 | ENST00000216446.9 | NP_057529.1 | |
PLEK2 | XM_047431262.1 | c.314C>T | p.Ala105Val | missense_variant | 3/8 | XP_047287218.1 | ||
PLEK2 | XM_047431263.1 | c.-92C>T | 5_prime_UTR_variant | 4/10 | XP_047287219.1 | |||
GPHN | XM_047430879.1 | c.1312+336691G>A | intron_variant | XP_047286835.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLEK2 | ENST00000216446.9 | c.314C>T | p.Ala105Val | missense_variant | 3/9 | 1 | NM_016445.3 | ENSP00000216446.4 | ||
PLEK2 | ENST00000554395.1 | c.116C>T | p.Ala39Val | missense_variant | 2/6 | 5 | ENSP00000450892.1 | |||
PLEK2 | ENST00000555803.5 | n.266C>T | non_coding_transcript_exon_variant | 2/5 | 3 | ENSP00000451218.1 | ||||
PLEK2 | ENST00000553387.1 | n.207+2185C>T | intron_variant | 5 | ENSP00000451023.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461742Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727182
GnomAD4 exome
AF:
AC:
17
AN:
1461742
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
727182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 03, 2024 | The c.314C>T (p.A105V) alteration is located in exon 3 (coding exon 3) of the PLEK2 gene. This alteration results from a C to T substitution at nucleotide position 314, causing the alanine (A) at amino acid position 105 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
D;T
Sift4G
Uncertain
T;T
Polyphen
P;.
Vest4
MutPred
Gain of catalytic residue at A102 (P = 0.0053);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.